Re: The crick didn’t rise, here’s the presentation, finally!
in response to
by
posted on
Oct 29, 2023 01:09PM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
Payzone
Just reading between the lines in the first paragraph of your post. If the TNBC trial was paused/suspended/stopped according to DM, that would have been Pfizer's decision since they are paying for the trial.
"we decided to pause - we would rather pursue low-hangin fruit in non competitive markets" infers that Pfizer and Zenith collectively made the decision.